BE906034A - WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS - Google Patents

WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS

Info

Publication number
BE906034A
BE906034A BE0/217600A BE217600A BE906034A BE 906034 A BE906034 A BE 906034A BE 0/217600 A BE0/217600 A BE 0/217600A BE 217600 A BE217600 A BE 217600A BE 906034 A BE906034 A BE 906034A
Authority
BE
Belgium
Prior art keywords
water
active ingredient
pharmaceutical compositions
compositions containing
therapeutic applications
Prior art date
Application number
BE0/217600A
Other languages
French (fr)
Inventor
Pierre-Noel Brasey
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of BE906034A publication Critical patent/BE906034A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Compositions pharmaceutiques aqueuses contenant de l'ubiquinone, un émulsifiant non ionique, un solvant hydroxylé, des agents anti-oxydants et éventuellement du diméthylacétamide. L'administration des compositions selon l'invention par les voies orales, parentérales et topiques sont hydrosolubles et stables, n'entrainant pas de phénomènes de précipitation du principe actif. Leur biodisponibilité améliorée (meilleure absorption du principe actif) entraine une efficacité thérapeutique accrue.Aqueous pharmaceutical compositions containing ubiquinone, a nonionic emulsifier, a hydroxylated solvent, antioxidants and optionally dimethylacetamide. The administration of the compositions according to the invention by the oral, parenteral and topical routes are water-soluble and stable, not causing precipitation phenomena of the active principle. Their improved bioavailability (better absorption of the active ingredient) leads to increased therapeutic efficacy.

BE0/217600A 1985-12-24 1986-12-23 WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS BE906034A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5525/85A CH667387A5 (en) 1985-12-24 1985-12-24 UBICHINONE AQUEOUS PHARMACEUTICAL FORMULATIONS.

Publications (1)

Publication Number Publication Date
BE906034A true BE906034A (en) 1987-04-16

Family

ID=4295081

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217600A BE906034A (en) 1985-12-24 1986-12-23 WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS

Country Status (7)

Country Link
JP (1) JPS62158209A (en)
BE (1) BE906034A (en)
CH (1) CH667387A5 (en)
DE (1) DE3643330A1 (en)
FR (1) FR2598320B1 (en)
GB (1) GB2184355B (en)
IT (1) IT1198247B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076433A1 (en) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Dental formulation

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250672B (en) * 1991-07-11 1995-04-21 Idb Holding Spa ORAL FORMULATIONS OF UBIDECARENONE IN AQUEOUS SOLUTION
ES2051643B1 (en) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS.
GR1001364B (en) * 1992-10-16 1993-10-29 Inverni Della Beffa Farma Ubidecarenone oral formulations in the form of aqueous solutions.
ATE330592T1 (en) * 1997-02-12 2006-07-15 Mse Pharmazeutika Gmbh USE OF 2,3-DIMETHOXY-5-METHYL-6-DECAPRENYL-1,4-BENZOQUINONE IN THE TREATMENT OF INCONTINENCE
EP1007018B1 (en) 1997-02-12 2003-10-08 MSE Pharmazeutika GmbH The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone in the treatment of tinnitus
US5925335A (en) * 1997-06-12 1999-07-20 C.S. Bioscience Inc. Dental formulation
EP0888774A3 (en) * 1997-06-30 1999-11-10 Soft Gel Technologies, Inc. Soft gel Coenzyme Q10 formulation
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
DE19944137A1 (en) * 1999-09-15 2001-03-22 Beiersdorf Ag O / W emulsions containing one or more biochinones and increased glycerin content
JP3742602B2 (en) * 2001-05-09 2006-02-08 株式会社カネカ Stable solution of reduced coenzyme Q
WO2005035477A1 (en) * 2003-10-08 2005-04-21 Kaneka Corporation Method of stabilizing compound having quinone skeleton and stabilized composition
AU2004326297B2 (en) * 2004-11-16 2008-08-07 Bioavailability, Inc. High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use
JP5999765B2 (en) * 2012-12-07 2016-09-28 バイオアバイラビリティ，インク． High concentration self-microemulsifying coenzyme Q10 preparation for nutritional use
JP5722299B2 (en) * 2012-12-07 2015-05-20 バイオアバイラビリティ，インク． High concentration self-microemulsifying coenzyme Q10 preparation for nutritional use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL275602A (en) * 1961-03-06
FR1334961A (en) * 1961-03-06 1963-08-16 Merck & Co Inc Stable aqueous solutions based on substituted benzoquinone
JPS498246B1 (en) * 1965-07-15 1974-02-25
GB1225979A (en) * 1967-03-23 1971-03-24
GB1317865A (en) * 1971-11-15 1973-05-23 Jujo Paper Co Ltd Biologically active composition
JPS5218811A (en) * 1975-08-01 1977-02-12 Eisai Co Ltd Preparation of aqueous solution of fat- soluble substances
JPS58113127A (en) * 1981-12-28 1983-07-05 Ajinomoto Co Inc Aqueous solution containing ubidecarenone
JPS6025918A (en) * 1983-07-25 1985-02-08 Ajinomoto Co Inc Aqueous solution containing fat-soluble drug

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076433A1 (en) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Dental formulation

Also Published As

Publication number Publication date
IT8622844A1 (en) 1988-06-23
JPS62158209A (en) 1987-07-14
CH667387A5 (en) 1988-10-14
GB8630158D0 (en) 1987-01-28
FR2598320B1 (en) 1990-11-02
GB2184355B (en) 1990-03-28
FR2598320A1 (en) 1987-11-13
GB2184355A (en) 1987-06-24
JPH0455404B2 (en) 1992-09-03
DE3643330A1 (en) 1987-06-25
IT8622844A0 (en) 1986-12-23
IT1198247B (en) 1988-12-21

Similar Documents

Publication Publication Date Title
BE906034A (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS
FR2430228A1 (en) SKIN DISEASE MEDICINE
ES2114569T3 (en) IMPROVED SKIN PENETRATION SYSTEM FOR THE IMPROVED TOPICAL ADMINISTRATION OF PHARMACES.
ES2113127T3 (en) DERIVATIVE OF ANDROSTENONE.
FR2356424A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON PHOPHONOFORMIC ACID USEFUL IN THE FIGHT AGAINST VIRAL INFECTIONS
ATE234634T1 (en) SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULPHOALKYL ETHERCYCLODEXTRIN AND A THERAPEUTIC ACTIVE INGREDIENT
FR2635265B1 (en) INTRAVENOUS PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN AS ACTIVE INGREDIENT AND PROCESS FOR THE PREPARATION THEREOF
MA28008A1 (en) PYRIDYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
ATE235895T1 (en) DRUG DELIVERY SYSTEM CONTAINING A HARD-PACKED, SOLID DRUG BASE
FR2392971A1 (en) PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCT CONTAINING SUCH SUBSTANCES
BR9810312A (en) Pharmaceutical composition that has marked antitumor activity and / or reduced side effects containing an antitumor agent and a derivative of hydroxy acid
BR9810729B1 (en) pharmaceutical composition for acid lipophilic compounds arranged as a self-emulsifying formulation.
FR2362833A1 (en) NEW PROSTAGLANDIN 5 DERIVATIVES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR2361901A1 (en) NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
ATE87484T1 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HUP0302635A2 (en) Phospholipid derivatives of valproic acid and mixtures thereof
ATE173627T1 (en) MEDICAL COMPOSITION
FR2554346B1 (en) ASSEMBLY AND METHOD FOR THE DELIVERY OF GANGLIOSIDES AND THEIR DERIVATIVES BY INHALATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO870560L (en) NEW PHARMACEUTICAL PREPARATION.
FR2398067A1 (en) NEW 4-PYRONES SUBSTITUTED IN POSITIONS 2, 3 AND 6 AND MEDICINAL PRODUCTS CONTAINING THEM
BE901963A (en) DOSED FORM OF ETOPOSIDE FOR ORAL USE.
ES2062329T3 (en) ANESTHETIC COMPOSITIONS BY ORAL WAY.
FR2367061A1 (en) NEW 13-THIAPROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2592043A1 (en) 2-CHLORO-12- (3-DIMETHYLAMINO-2-METHYLPROPYL) -12H-DIBENZO- (D, G) (1, 3, 6) -OPTICALLY ACTIVE DIOXAZOCINS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2400362A1 (en) ANTI-ATHEROSMATIC ACTION DRUGS BASED ON NEW PYRIDINE DERIVATIVES

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SEUREF A.G.

Effective date: 19931231